Gender-modulated endogenous baseline neuropeptide Y Y1-receptor activation in the hindlimb of Sprague-Dawley rats

Journal of Physiology

Volumn 562, Issue 1, 2005, Pages 285-294

  Jackson, Dwayne N ^a   Milne, Kevin J ^a   Noble, Earl G ^a   Shoemaker, J Kevin ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y1 RECEPTOR; PRAZOSIN; NEUROPEPTIDE Y;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME MECHANISM; FEMALE; HINDLIMB; MALE; MUSCLE BLOOD VESSEL; MUSCLE FIBER MEMBRANE CONDUCTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; RAT STRAIN; SEX DIFFERENCE; WESTERN BLOTTING; ADULT; BLOOD VESSEL FUNCTION; BLOOD VESSEL TONE; GASTROCNEMIUS MUSCLE; HEART RATE; MEAN ARTERIAL PRESSURE; MUSCLE PERFUSION; SKELETAL MUSCLE; SOLEUS MUSCLE; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION; VASCULAR CONDUCTANCE;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ARGININE; BLOOD PRESSURE; BLOTTING, WESTERN; FEMALE; FEMORAL ARTERY; HEART RATE; HINDLIMB; IMMUNOASSAY; MALE; NEUROPEPTIDE Y; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, NEUROPEPTIDE Y; REGIONAL BLOOD FLOW; SEX CHARACTERISTICS;

EID: 13444282524     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.076141     Document Type: Article

References (42)

1. Armstrong RB & Laughlin MH (1984). Exercise blood flow patterns within and among rat muscles after training. Am J Physiol 246, H59-68.
2. Bergdahl A, Nilsson T, Cantera L, Nilsson L, Sun XY, Hedner T, Erlinge D, Valdemarson S & Edvinsson L (1996). Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor. Eur J Pharmacol 316, 59-64.
3. Bischoff A, Gerbracht A & Michel MC (2000). Gender and hypertension interact to regulate neuropeptide Y receptor responsiveness. Naunyn Schmiedebergs Arch Pharmacol 361, 173-180.
4. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
5. Buckwalter JB, Hamann JJ, Kluess HA & Clifford PS (2004). Vasoconstriction in exercising skeletal muscles: a potential role for neuropeptide Y? Am J Physiol Heart Circ Physiol 287, H144-149.
6. Dynon MK, Jarrott B & Louis WJ (1983). Tissue distribution and hypotensive effect of prazosin in the conscious rat. J Cardiovasc Pharmacol 5, 235-239.
7. Edvinsson L, Ekblad E, Hakanson R & Wahlestedt C (1984a . Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol 83, 519-525.
8. Edvinsson L, Emson P, McCulloch J, Tatemoto K & Uddman R (1984b). Neuropeptide Y: immunocytochemical localization to and effect upon feline pial arteries and veins in vitro and in situ. Acta Physiol Scand 122, 155-163.
9. Ekblad E, Edvinsson L, Wahlestedt C, Uddman R, Hakanson R & Sundler F (1984). Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept 8, 225-235.
10. Ekelund U & Erlinge D (1997). In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle. Br J Pharmacol 120, 387-392.
11. Fallgren B, Arlock P & Edvinsson L (1993). Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction by an intracellular calcium-dependent mechanism. J Auton Nerv Syst 44, 151-159.
12. Franco-Cereceda A & Liska J (1998). Neuropeptide Y Y1 receptors in vascular pharmacology. Eur J Pharmacol 349, 1-14.
13. Glenn TC, Krause DN & Duckles SP (1997). Vascular responses to neuropeptide Y are greater in female than male rats. Naunyn Schmiedebergs Arch Pharmacol 355, 111-118.
14. Glover WE (1985). Increased sensitivity of rabbit car artery to noradrenaline following perivascular nerve stimulation may be a response to neuropeptide Y released as cotransmitter. Clin Exp Pharmacol Physiol 12, 227-230.
15. Hanko JH, Tornebrandt K, Hardebo JE, Kahrstrom J, Nobin A & Owman C (1986). Neuropeptide Y induces and modulates vasoconstriction in intracranial and peripheral vessels of animals and man. J Auton Pharmacol 6, 117-124.
16. Hess HJ (1975). Prazosin: biochemistry and structure-activity studies. Postgrad. Medical, Spec No, 9-17.
17. Itoi K, Mouri T, Takahashi K, Sasaki S, Imai Y & Yoshinaga K (1986). Synergistic pressor action of neuropeptide Y and norepinephrine in conscious rats. J Hypertens Suppl 4, S247-250.
18. Jackson DN, Noble EG & Shoemaker JK (2004). Y1- and α1-receptor control of basal hindlimb vascular tone. Am. J. Physiol Regul. Integr. Comp Physiol 287, R228-R223.
19. Johnson PC (1989). The myogenic response in the microcirculation and its interaction with other control systems. J Hypertens Supplement 7, S33-S39.
20. Jones PP, Snitker S, Skinner JS & Ravussin E (1996). Gender differences in muscle sympathetic nerve activity: effect of body fat distribution. Am J Physiol 270, E363-366.
21. Laughlin MH & Armstrong RB (1983). Rat muscle blood flows as a function of time during prolonged slow treadmill exercise. Am J Physiol 244, H814-824.
22. Lee EW, Michalkiewicz M, Kitlinska J, Kalezic I, Switalska H, Yoo P, Sangkharat A, Ji H, Li L, Michalkiewicz T, Ljubisavljevic M, Johansson H, Grant DS & Zukowska Z (2003). Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest 111, 1853-1862.
23. Lundberg JM, Franco-Cereceda A, Hemsen A, Lacroix JS & Pernow J (1990). Pharmacology of noradrenaline and neuropeptide tyrosine (NPY)-mediated sympathetic cotransmission. Fundam Clin Pharmacol 4, 373-391.
24. Malmstrom RE (1997). Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control. Acta Physiol Scand Supplement 636, 1-55.
25. Mancia G, Ferrari A, Gregorini L, Ferrari MC, Bianchim C, Terzoli L, Leonetti G & Zanchettie A (1980). Effects of prazosin on autonomic control of circulation in essential hypertension. Hypertension 2, 700-707.
26. Massingham R & Hayden ML (1975). A comparsion of the effects of prazosin and hydrallazine on blood pressure, heart rate and plasma renin activity in conscious renal hypertensive dogs. Eur J Pharmacol 30, 121-124.
27. Mentlein R & Roos T (1996). Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells. Peptides 17, 709-720.
28. Morris JL, Gibbins IL, Furness JB, Costa M & Murphy R (1985). Co-localization of neuropeptide Y, vasoactive intestinal polypeptide and dynorphin in non-noradrenergic axons of the guinea pig uterine artery. Neurosci Lett 62, 31-37.
29. Neild TO (1987). Actions of neuropeptide Y on innervated and denervated rat tail arteries. J Physiol 386, 19-30.
30. Ng AV, Callister R, Johnson DG & Seals DR (1993). Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 21, 498-503.
31. Oates HF, Graham RM, Stoker LM & Stokes GS (1976). Haemodynamic effects of prazosin. Arch Int Pharmacodyn Ther 224, 239-247.
32. Pernow J, Ohlen A, Hokfelt T, Nilsson O & Lundberg JM (1987). Neuropeptide Y. presence in perivascular noradrenergic neurons and vasoconstrictor effects on skeletal muscle blood vessels in experimental animals and man. Regul Pept 19, 313-324.
33. Qureshi NU, Dayao EK, Shirali S, Zukowska-Grojec Z & Hauser GJ (1998). Endogenous neuropeptide Y mediates vasoconstriction during endotoxic and hemorrhagic shock. Regul Pept 75-76, 215-220.
34. Sato K, Crofton JT, Wang YX & Share L (1995). Effects of gender on the central actions of neuropeptide Y and norepinephrine on vasopressin and blood pressure in the rat. Brain Res 689, 71-78.
35. Shoemaker JK, Hogeman CS, Khan M, Kimmerly DS & Sinoway LI (2001). Gender affects sympathetic and hemodynamic response to postural stress. Am J Physiol Heart Circ Physiol 281, H2028-2035.
36. Sundler F, Böttcher G, Ekblad E & Håkanson R (1993). PP, PYY, and NPY: Occurance and distribution in the periphery. In The Biology of Neuropeptide Y and Related Peptides, ed. Colmers W F & Wahlestedt C. Humana Press Inc., Tolowa.
37. Terjung RL & Engbretson BM (1988). Blood flow to different rat skeletal muscle fiber type sections during isometric contractions in situ. Med Sports Exerc 20, S124-130.
38. Wahlestedt C, Edvinsson L, Ekblad E & Hakanson R (1985). Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J Pharmacol Exp Ther 234, 735-741.
39. Zukowska-Grojec Z (1995). Neuropeptide Y. A novel sympathetic stress hormone and more. Ann N Y Acad Sci 771, 219-233.
40. Zukowska-Grojec Z, Shen GH, Capraro PA & Vaz CA (1991). Cardiovascular, neuropeptide Y, and adrenergic responses in stress are sexually differentiated. Physiol Behav 49, 771-777.
41. Zukowska-Grojec Z & Vaz AC (1988). Role of neuropeptide Y (NPY) in cardiovascular responses to stress. Synapse 2, 293-298.
42. Zukowska-Grojec Z & Wahlestedt C (1993). Origin and actions of neuropeptide Y in the cardiovascular system. In The Biology of Neuropeptide Y and Related Peptide, ed. Colmers WF & Wahlestedt C, pp. 315-388. Humana Press, Totowa.